- Home
- CUE vs GOCO Comparison
CUE vs GOCO Comparison
Compare CUE & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- GOCO
- Stock Information
- Founded
- CUE 2014
- GOCO 2001
- Country
- CUE United States
- GOCO United States
- Employees
- CUE N/A
- GOCO N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- GOCO Specialty Insurers
- Sector
- CUE Health Care
- GOCO Finance
- Exchange
- CUE Nasdaq
- GOCO Nasdaq
- Market Cap
- CUE 61.1M
- GOCO 70.3M
- IPO Year
- CUE 2018
- GOCO 2020
- Fundamental
- Price
- CUE $0.70
- GOCO $4.07
- Analyst Decision
- CUE Strong Buy
- GOCO Hold
- Analyst Count
- CUE 2
- GOCO 1
- Target Price
- CUE $3.00
- GOCO $12.00
- AVG Volume (30 Days)
- CUE 267.2K
- GOCO 38.4K
- Earning Date
- CUE 11-13-2025
- GOCO 11-06-2025
- Dividend Yield
- CUE N/A
- GOCO N/A
- EPS Growth
- CUE N/A
- GOCO N/A
- EPS
- CUE N/A
- GOCO N/A
- Revenue
- CUE $8,286,000.00
- GOCO $822,444,000.00
- Revenue This Year
- CUE N/A
- GOCO $2.06
- Revenue Next Year
- CUE N/A
- GOCO $5.47
- P/E Ratio
- CUE N/A
- GOCO N/A
- Revenue Growth
- CUE N/A
- GOCO 17.46
- 52 Week Low
- CUE $0.54
- GOCO $4.03
- 52 Week High
- CUE $1.99
- GOCO $21.00
- Technical
- Relative Strength Index (RSI)
- CUE 39.09
- GOCO 31.08
- Support Level
- CUE $0.69
- GOCO $4.03
- Resistance Level
- CUE $0.81
- GOCO $4.54
- Average True Range (ATR)
- CUE 0.04
- GOCO 0.19
- MACD
- CUE -0.01
- GOCO -0.02
- Stochastic Oscillator
- CUE 6.00
- GOCO 5.81
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.